Tenet Healthcare Rating Reiterated by CRT Capital (THC)

Share on StockTwits

Tenet Healthcare (NYSE: THC)‘s stock had its “buy” rating reiterated by analysts at CRT Capital in a research report issued to clients and investors on Monday, ARN reports. They currently have a $51.00 target price on the stock. CRT Capital’s price target would suggest a potential upside of 8.42% from the stock’s previous close.

Tenet Healthcare (NYSE: THC) traded down 2.91% on Monday, hitting $45.67. Tenet Healthcare has a 1-year low of $17.24 and a 1-year high of $49.47. The stock’s 50-day moving average is currently $44.64. The company’s market cap is $4.727 billion.

Tenet Healthcare (NYSE: THC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.33 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.31 by $0.02. The company had revenue of $2.59 billion for the quarter, compared to the consensus estimate of $2.46 billion. During the same quarter in the prior year, the company posted $0.13 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Analysts expect that Tenet Healthcare will post $2.84 EPS for the current fiscal year.

A number of other firms have also recently commented on THC. Analysts at UBS AG raised their price target on shares of Tenet Healthcare from $50.00 to $55.00 in a research note to investors on Thursday, May 9th. They now have a “buy” rating on the stock. Separately, analysts at Mizuho raised their price target on shares of Tenet Healthcare from $41.00 to $51.00 in a research note to investors on Monday, May 6th. They now have a “buy” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Tenet Healthcare from $44.00 to $52.00 in a research note to investors on Thursday, May 2nd. They now have an “outperform” rating on the stock.

Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Tenet Healthcare currently has an average rating of “Buy” and an average target price of $44.24.

Tenet Healthcare Corporation, and its subsidiaries (NYSE: THC) is an investor-owned health care services company whose subsidiaries and affiliates own and operate acute care hospitals, ambulatory surgery centers, diagnostic imaging centers and related health care facilities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

Allergen Bid Might Be Better for Teva
Allergen Bid Might Be Better for Teva
Biogen Slashes Forecast on Weakness of Tecfidera
Biogen Slashes Forecast on Weakness of Tecfidera
Whirlpool Profit for the Quarter Drops on Strong Dollar
Whirlpool Profit for the Quarter Drops on Strong Dollar
Morgan Stanley Revenue Helps It Beat the Street
Morgan Stanley Revenue Helps It Beat the Street
Hertz Projecting Earnings at Top of Forecasted Range
Hertz Projecting Earnings at Top of Forecasted Range
Earnings at Goldman Sachs Tumble
Earnings at Goldman Sachs Tumble


Advertisement
Advertisement
© 2006-2015 Ticker Report. Google+.